Doc, I agree: it's an excuse (not a "reason," and

Doc, I agree: it's an excuse (not a "reason," and not an "explanation".

That said, I also agree that the focus is the IPO, AZ, and Excellagen. (I disagree that the vaccine should be a focus, because it remains a crapshoot.) These are the issues unique to Generex/NuGen, and are what will make them profitable long-term, if anything is going to do that. I do not give a fuzzy rat's patootey about a vaccine; it initially had potential, but I have not seen anything truly substantial about the company's progress that somehow will attract the attention of legitimate investors (governmental or private), else it would have happened already. And I am not talking about China; I no more believe that China will come through on its promises than I do that they will cease enslaving and torturing Muslims in their country, or stop appropriating IP from the US or any other country. It would be great if something positive happened in that arena, but it is a lottery ticket and a pipe dream.

"The rest of that stuff" may be comparatively insignificant for the moment, but I do not see it as insignificant in the long run. That is especially true given that the links on the new website make reference to a number of those products.

So, we will hear what CEO/CoB/President Moscato has to say in a little more than a week. I will be hard-pressed, however, to remain remotely optimistic if all we hear is (1) wait a little longer or (2) the equivalent of "it's somebody else's fault."